Quality of life from time of surgery at baseline, and at 1, 3, 6, and 12 months (n=56)
| QLQ-C30 | Initial (before surgery) | 1 month | 3 months | 6 months | 12 months | Continent vs non-continent at 12 months (P value) |
| General health and global quality of life | 58.3 (0–100) | 41.7 (0–83.3) | 50 (16.7–83.3) | 58.3 (8.3–100) | 58.3 (0–100) | 0.891 |
| Functional scales | ||||||
| Physical | 80 (20–100) | 46.7 (0–100) | 73.3 (6.7–100) | 80 (0–100) | 86.7 (26.7–100) | 0.195 |
| Role | 83.3 (0–100) | 33.3 (0–100) | 75 (0–100) | 83.3 (0–100) | 83.3 (0–100) | 0.322 |
| Emotional | 58.3 (0–100) | 66.7 (0–100) | 75 (0–100) | 79.2 (16.7–100) | 75 (33.3–100) | 0.172 |
| Cognitive | 83.3 (0–100) | 66.7 (0–100) | 83.3 (33.3–100) | 91.7 (0–100) | 83.3 (16.7–100) | 0.517 |
| Social | 66.7 (0–100) | 50 (0–100) | 66.7 (0–100) | 66.7 (0–100) | 66.7 (0–100) | 0.413 |
| Symptom scales | ||||||
| Fatigue | 38.9 (0–100) | 77.8 (11.1–100) | 44.4 (0–100) | 44.4 (0–100) | 27.8 (0–100) | 0.657 |
| Pain | 33.3 (0–100) | 33.3 (0–100) | 33.3 (0–100) | 16.7 (0–100) | 16.7 (0–100) | 0.517 |
| Insomnia | 33.3 (0–100) | 33.3 (0–100) | 33.3 (0–100) | 0 (0–100) | 33.3 (0–100) | 0.219 |
| Constipation | 16.7 (0–100) | 0 (0–100) | 0 (0–100) | 0 (0–66.7) | 0 (0–100) | 0.847 |
| Financial difficulties | 16.7 (0–100) | 0 (0–100) | 0 (0–66.7) | 0 (0–100) | 0 (0–66.7) | 0.432 |
| Nausea/vomiting | 0 (0–83.3) | 16.7 (0–83.3) | 0 (0–83.3) | 0 (0–66.7) | 0 (0–50) | 0.785 |
| Dyspnea | 0 (0–100) | 0 (0–100) | 0 (0–33.3) | 0 (0–66.7) | 0 (0–33.3) | 0.375 |
| Loss of appetite | 33.3 (0–100) | 66.7 (0–100) | 33.3 (0–100) | 0 (0–100) | 0 (0–33.3) | 0.385 |
| Diarrhea | 0 (0–100) | 33.3 (0–100) | 0 (0–100) | 33.3 (0–100) | 0 (0–66.7) | 0.657 |
| QLQ-OV28 | ||||||
| Abdominal complaints | 22.2 (0–72.2) | 33.3 (0–83.3) | 25 (0–77.8) | 22.2 (0–66.7) | 16.7 (0–55.6) | 0.973 |
| Peripheral neuropathy | 0 (0–100) | 0 (0–100) | 16.7 (0–66.7) | 16.7 (0–66.7) | 16.7 (0–50) | 0.973 |
| Menopausal symptoms | 33.3 (0–100) | 0 (0–83.3) | 8.3 (0–66.7) | 8.3 (0–83.3) | 8.3 (0–100) | 0.785 |
| Body image | 33.3 (0–100) | 50 (0–100) | 50 (0–100) | 33.3 (0–100) | 33.3 (0–100) | 0.277 |
| Attitude towards disease/treatment | 72.2 (0–100) | 77.8 (0–100) | 66.7 (0–100) | 66.7 (11.1–100) | 61.1 (0–100) | 0.707 |
| Chemotherapy side effects | 26.7 (0–93.3) | 26.7 (0–73.3) | 20 (0–60) | 20 (0–60) | 15 (0–60) | 0.322 |
Values are median (range).
QLQ, quality of life questionnaire.